...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Wow…

Well he must have said something - we're down a 100% sitting at zero. The average or even larger investor will be impressed when they see us trading on the otc/ so called expert market. Every play is down

Get out of the way mccaffray - you really do suck as a Biotech CEO , open your fricking eyes!! Why is he allowed to continue to present for us , pathetic.

  

Share
New Message
Please login to post a reply